-
Bufalin, CENPA, and Glycolysis in HCC
2026-10-01
A 2026 Molecular and Cellular Endocrinology study links Bufalin exposure to reduced CENPA expression, glycolytic activity, PI3K/AKT phosphorylation, and migration in hepatocellular carcinoma models. Its integrated bioinformatics, cell-based, docking, and preliminary xenograft evidence proposes CENPA as a mechanistic connection between cancer metabolism and Bufalin activity, while leaving direct target engagement and therapeutic efficacy unresolved.
-
In Situ tRNA Synthesis Sustains Cell-Free Translation
2026-10-01
Li, Baranwal, and Maerkl developed a route for producing a complete 21-tRNA decoding set directly inside the PURE recombinant cell-free system. By combining transcriptional optimization, template engineering, and RNA processing, the study supported steady-state protein expression in microfluidic chemostats for up to 20 hours, an important step toward self-regenerating biochemical systems.
-
V5 Epitope Tag Peptide: Assay Reliability
2026-09-30
Learn how the V5 Epitope Tag Peptide (SKU A6005) can add an orthogonal protein-expression readout to cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide covers tag selection, assay compatibility, formulation, interpretation, and supplier reliability using product specifications and published antibody-screening evidence.
-
Spiroplasma Entry into Drosophila S2 Cells
2026-09-30
Wei and colleagues established a Drosophila Schneider 2 cell model showing that Spiroplasma eriocheiris causes cellular injury and enters host cells through clathrin-dependent endocytosis and macropinocytosis. The study provides a tractable invertebrate system for dissecting pathogen entry, while its inhibitor-based design also highlights the need to distinguish pathway involvement from direct molecular mechanism.
-
Brain-to-Spinal Circuits in Mechanical Allodynia
2026-09-29
Huo and colleagues identify a contralateral lPBN–hypothalamus–spinal dorsal horn pathway that regulates both the laterality and persistence of mechanical allodynia in mice. Their projection-specific perturbations show that dynorphin signaling from hypothalamic neurons and spinal κ-opioid receptors acts as an inhibitory gate against bilateral and sustained pain hypersensitivity.
-
Macrophage EV miR-660 in Breast Cancer Metastasis
2026-09-29
The reference study identifies macrophage-derived extracellular vesicles as a route for delivering miR-660 to breast cancer cells, where it suppresses KLHL21 and activates the IKKβ/NF-κB p65 axis. Its combined tissue, cell, and mouse-model design connects tumor-associated macrophage communication with metastatic behavior and provides a framework for studying extracellular-vesicle-mediated signaling.
-
SMYD2 Inhibition Limits Cisplatin-Induced Renal Fibrosis
2026-09-28
The study identifies elevated SMYD2 as a feature of cisplatin-induced chronic kidney injury and reports that pharmacological inhibition with AZ505 or LLY507 reduces renal dysfunction, fibrosis, and inflammatory signals. Its findings connect SMYD2 activity with EMT-related changes and Smad3/STAT3 signaling, supporting further investigation of this enzyme as a regulator of renal injury while leaving clinical benefit unproven.
-
LSKL Protects Granulosa Cells in a DHEA PCOS Model
2026-09-27
A rat and cell-model study links THBS1 inhibition by LSKL with reduced DHEA-associated oxidative stress and apoptosis, alongside increased PI3K/AKT pathway activity. Its combined cellular and ovarian findings support further investigation of THBS1 in PCOS, while leaving questions about mechanism, measurement specificity, and clinical relevance.
-
HotStart 2X Green qPCR: From Signal to Mechanism
2026-09-26
See how HotStart 2X Green qPCR Master Mix can support rigorous validation of a proposed circRNA–miRNA–mRNA pathway in bronchopulmonary dysplasia research. This article connects assay design to the evidence chain in a recent circ-ECH1 study, while explaining what SYBR Green measurements can—and cannot—establish.
-
Anti-HMGB1 Rabbit Monoclonal Antibody Workflow
2026-09-26
Anti-HMGB1 Rabbit Monoclonal Antibody MA3057 supports HMGB1 detection in human, mouse, and rat samples by Western blot, immunohistochemistry, and flow cytometry. Use it for research assays with assay-specific optimization; it is not intended for diagnostic, medical, or therapeutic use.
-
CHK1 Inhibition in ER/PR-Stratified Breast Cancer
2026-09-25
The study shows that checkpoint kinase 1 (CHK1) inhibition has different effects across receptor-defined breast cancer models: it enhances adriamycin sensitivity in triple-negative cells but does not do so in ER+/PR+/HER2− cells, where CHK1 inhibition instead has single-agent activity. These findings support evaluating ER, PR, and HER2 status when designing preclinical CHK1-targeted strategies, while underscoring the need for clinical validation.
-
EMD638683: A Research-Grade SGK1 Inhibitor
2026-09-25
EMD638683 is a small-molecule SGK1 inhibitor used to study SGK signaling, including endothelial stiffness, NDRG1 phosphorylation, and tumor-related models. A vascular study reports that EMD638683 reduced aldosterone- and high-salt-induced endothelial stiffness and actin polymerization in cultured human aortic endothelial cells.
-
Promethazine HCl for Macrophage Assays
2026-09-24
Use Promethazine HCl to investigate H1-receptor blockade alongside macrophage ROS, lysosomal activity, and autophagy—while controls help distinguish host-cell effects from direct antibacterial activity. This guide turns recent phenothiazine findings into a cautious, testable workflow with formulation and troubleshooting advice.
-
GLT-1, CB1-CREB Signaling, and TBI Cognition
2026-09-24
A 2025 mouse study links traumatic brain injury to reduced astrocytic GLT-1 through a 2-AG–CB1–CREB signaling mechanism. Its findings suggest that restoring glutamate clearance may lessen neuronal apoptosis and cognitive dysfunction, while highlighting important limits on translation beyond the tested model.
-
O-GlcNAcylation Rewires Wnt-Driven Bone Formation
2026-09-23
The reference study identifies O-GlcNAcylation as a metabolic effector of Wnt-stimulated osteogenesis, linking Wnt3a signaling to PDK1 stabilization, aerobic glycolysis, bone formation, and fracture repair. Its combined genetic, biochemical, metabolic, and in vivo strategy provides a framework for testing how signaling pathways control osteoblast energy metabolism.